EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC 4.0

Association between remnant cholesterol and chronic kidney disease: Systematic review and meta‐analysis

Paschalis Karakasis iD, Dimitrios Patoulias iD, Manfredi Rizzo iD, Nikolaos Fragakis, Christos S Mantzoros iD

Diabetes, Obesity and Metabolism · 2025-05 · 27 (5) · 2573-2583

DOI: 10.1111/dom.16258 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 14.02.2025. Verfasst von Paschalis Karakasis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Cardiology, Hippokration General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Cholesterol, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Adequate lipid control has emerged as a key factor in the prevention and management of chronic kidney disease (CKD). Remnant cholesterol (RC), a lipoprotein with an established association with cardiovascular risk, has been investigated in the context of CKD. Given the conflicting results from recent studies, we performed this meta‐analysis to summarize the existing evidence on the association between RC and CKD.

Methods

Medline, Cochrane Library and Scopus were searched until 16 September 2024. Double‐independent study selection, data extraction and quality assessment were performed. Evidence was pooled using random‐effects meta‐analyses. We set as primary end‐point of interest the association between RC and CKD.

Results

Twelve studies (4 139 674 participants) were included. Participants with RC values in the highest quantile had significantly greater odds of CKD compared to those in the lowest quantile (Odds Ratio [OR] = 1.46, 95% confidence interval [CI] = 1.26–1.68). In a sensitivity analysis confined to subjects with type 2 diabetes (T2D), those in the higher RC quantile also exhibited significantly increased odds of CKD compared to those in the lowest quantile (OR = 1.46, 95% CI = 1.20–1.78). A significant inverse association was observed between RC and estimated glomerular filtration rate (Mean Difference [MD] = −1.43 mL/min/1.73 m 2 for each 1 mmol/L increase in RC, 95% CI = [−2.67, −0.19]). Additionally, individuals with T2D‐related CKD had a 24% increased risk of progression to end‐stage renal disease for each 1 standard deviation increase in RC (Hazard Ratio [HR] = 1.24, 95% CI = 1.04–1.47).

Conclusions

RC is directly associated with higher risk for CKD. Beyond traditional lipid markers, greater emphasis should be placed on RC levels in individuals with or at risk for CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicCholesterolDiabetes Mellitus, Type 2HumansRisk Factors

Stichwörter der Autor:innen

chronic kidney diseaseend‐stage renal diseaseestimated glomerular filtration rateremnant cholesterol

Substanzen

Cholesterol

Autor:innen und Institutionen

  • Second Department of Cardiology, Hippokration General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Second Propedeutic Department of Internal Medicine, Faculty of Medicine, School of Health Sciences Aristotle, University of Thessaloniki, Thessaloniki, Greece.
  • Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates.
  • School of Medicine, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (Promise), University of Palermo, Palermo, Italy.
  • Beth Israel Deaconess Medical Center and Boston VA Healthcare System, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Paschalis Karakasis, Dimitrios Patoulias, Manfredi Rizzo, Christos S Mantzoros

Zitieren

APA

Karakasis, P., Patoulias, D., Rizzo, M., Fragakis, N., & Mantzoros, C. S. (2025). Association between remnant cholesterol and chronic kidney disease: Systematic review and meta‐analysis. Diabetes, Obesity and Metabolism, 27(5), 2573-2583. https://doi.org/10.1111/dom.16258

Vancouver

Karakasis P, Patoulias D, Rizzo M, Fragakis N, Mantzoros CS. Association between remnant cholesterol and chronic kidney disease: Systematic review and meta‐analysis. Diabetes, Obesity and Metabolism. 2025;27(5):2573-2583. doi:10.1111/dom.16258

BibTeX
@article{Karakasis2025,
  author = {Karakasis, Paschalis and Patoulias, Dimitrios and Rizzo, Manfredi and Fragakis, Nikolaos and Mantzoros, Christos S},
  title = {Association between remnant cholesterol and chronic kidney disease: Systematic review and meta‐analysis},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  volume = {27},
  number = {5},
  pages = {2573--2583},
  doi = {10.1111/dom.16258}
}
Kostenlos starten →